摘要
目的探讨氩离子激光对中心性浆液性脉络膜视网膜病变(CSC)的疗效。方法对62例(64只眼)经荧光素眼底血管造影(FFA)确诊为CSC的患者随机分为激光组32只眼和药物组32只眼,激光组采用氩绿激光治疗,药物组采用活血化瘀药物及多种微量元素静脉滴注,分别在治疗后10d、20d复查视力、眼底情况。结果激光组激光10d后31只眼治愈,占96.9%;20d31只眼治愈,占96.9%;药物组治疗后10d,16只眼(50%)治愈;20d时19只眼治愈,占59.4%。经χ2检验,两者有显著性差异。随访半年至1年,激光组仅1只眼复发,占3.1%,药物组9只眼复发,占28.1%,经χ2检验,两者也有显著性差异。发病在1个月以内的CSC早期采用激光治疗效果好。结论氩激光治疗CSC是一种有效的治疗方法。
Objective To discuss the clinical effect of argon laser in treatment of central serous chorioretinopathy （CSC） . Methods 64 eyes of 62 patients with CSC diagnosed by funds fluorescein angiography（FFA） were divided into laser group （ 32 eyes ） and drug group （ 32 eyes ）. The laser group were treated by argon green laser, and the drug group were given drugs of the circulation of blood and multi-trace dements by intravenous injection. The visual acuitiesy and fundus in both groups were examined at 10 days ,20 days after therapy respectively. Results In laser group, there were 31 eyes （96. 9% ）recovered at 10 days and 20 days after treatment. While in drug group,16 eyes （50%） and 19 eyes （59.4%） were recovered at 10 days and 20 days respectively. By x^2 test,the difference was statistically significant. During the foUowup for more than half a year,only one eye（3.1% ） recurred in laser group, while 9 eyes （28.1%） recurred in drug group . The effect was great ff laser was immediately used as a therapeutic method once CSC happened in one month. Conclusion Argon laser is an accurate and effective method in treatment of CSC.
出处
《临床眼科杂志》
2009年第2期119-121,共3页
Journal of Clinical Ophthalmology
